FORA Capital’s Akcea Therapeutics Inc AKCA Stock Holding History
Bought
Maintained
Sold
FORA Capital's AKCA Position: Q4 2020 in Review
FORA Capital sold out of Akcea Therapeutics Inc (AKCA) in Q4 2020, closing a stake of 1,765 shares — an estimated $32K sold.
FORA Capital first reported a position in AKCA in Q3 2020 and held it in 1 quarter. The position peaked at $32K in Q3 2020. 0 funds tracked by Wall St. Rank hold AKCA as of Q4 2020.
- FORA Capital reported no remaining Akcea Therapeutics Inc position as of Q4 2020 after selling out during the quarter.
- FORA Capital sold 1,765 Akcea Therapeutics Inc shares in Q4 2020, an estimated $32K.
- FORA Capital first reported a position in Akcea Therapeutics Inc in Q3 2020 and held it in 1 quarter.
- FORA Capital's Akcea Therapeutics Inc position peaked at $32K in Q3 2020.
- 0 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q4 2020.
Based on FORA Capital's 13F filing for Q4 2020, filed 12 Feb 2021.